Harbinger Health’s Post

Direct oral #anticoagulants are an effective option for preventing recurrent #VTE in patients with #cancer who wish to avoid burdensome injections https://lnkd.in/dK3w9CfP

Socially vulnerable patients with advanced prostate cancer seem to adhere to specialty medication therapies more often when they receive care from a 340B program-participating hospital than at a non-participating hospital, according to a new study. Researchers publishing in an American Cancer Society medical journal studied seven years of Medicare claims and found that the frequency of expensive specialty drug prescriptions for treating prostate cancer did not change between 340B and non-340B hospitals, but when 2 patients did receive such care, they tended to more often take their medication as prescribed from a prescriber at a participating hospital. https://lnkd.in/g5wsCxxX #340B #CareAccess #HealthDisparities #SDOH #PatientEngagement

🔍 What is Ibrutinib? 🧬 Ibrutinib is a targeted therapy known as a Bruton's tyrosine kinase (BTK) inhibitor. It is used to treat certain cancers like mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and Waldenström’s macroglobulinemia (WM). 🧬 It works by blocking the BTK protein, which is necessary for the growth and survival of cancer cells. What are some key benefits? 💡 Inhibits cancer cell growth: Ibrutinib stops the signals that allow cancer cells to multiply, slowing down disease progression. 💡 Improves survival rates: Clinical trials have shown a significant improvement in survival for patients with CLL and other types of blood cancer. 💡 Well-tolerated: Compared to traditional chemotherapy, Ibrutinib is often better tolerated, allowing patients to continue treatment longer. What is Ibrutinib's safety profile? ⚠️ Common adverse events: These include diarrhea, fatigue, and musculoskeletal pain. ⚠️ Serious risks: There is a risk of bleeding, infections, and arrhythmias. Patients with heart conditions should be carefully monitored. ⚠️ Monitoring: Regular monitoring of blood counts and heart function is crucial while on Ibrutinib. 🌍 Ongoing research: Ibrutinib is being studied in combination with other therapies for various types of cancers, with the goal of expanding its use and improving patient outcomes. 👣 Take your PV to the #NextLevel with us! 🚀 #Pharmacovigilance #Ibrutinib #TargetedTherapies #DrugSafety #PatientCare #HealthcareInnovation

On this #WorldCancerDay we recognize the challenges and uncertainties millions of people around the world face at the hands of this disease. Spencer Health Solutions was founded after CEO, Thomas Rhoads , recognized the difficulty cancer patients face in managing their complex medication regimens when his father was battling glioblastoma. The spencer SmartHub™ was developed to ensure all patients get the maximum therapeutic benefits from their medications while alleviating the stress of managing regimens themselves. Learn more about how spencer® supports oncology patients: https://lnkd.in/e_A_kvi2

Lung cancer causes nearly 160,000 U.S. deaths per year. However, only 30% of lung cancer cases are detected early. Omar Atiq, MD, a medical oncologist shares what patients need to know about lung cancer screening and prevention: 1. Smoking is the biggest risk factor. 2. Yearly screenings are important for patients with a history of smoking who are between the ages of 50 and 80. 3. There is a low risk of repeated low-dose CT scans causing cancer, so patients must weigh the benefits vs. the risks. 4. How long ago you quit smoking should not be a factor in whether you get screened. #LungCancer #Oncology #LungCancerScreening

Find out the research article Title: Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression. DOI: https://lnkd.in/g47uuX9G Discover how common cholesterol-lowering drugs, known as statins, might hold the key to cancer prevention. Learn about groundbreaking research that links statins to reduced cancer risk through inflammation control. Don’t miss out on this potential game-changer in cancer prevention! #Statins #CancerPrevention #ChronicInflammation #HeartHealth #IL33 #Cholesterol #CholesterolLowering #CancerResearch #Inflammation #Pitavastatin #HealthBreakthrough #ImmuneSystem #CancerRisk #HealthTips #Prevention #HealthInnovation #TLR3 #TLR4 #TBK1 #IRF3 #PancreaticCancer #HarvardResearch #MedicalBreakthrough #CholesterolDrugs #MassGeneralHospital #Immunology #Medicine #HealthBenefits #Cytokines #StatinBenefits #CancerTreatment #Oncology #ChronicDisease #HealthyLiving #HealthAwareness #Wellness #Healthcare #StatinDrugs #CancerAwareness #ScienceNews #MedicalResearch #StudyResults #DrugDiscovery #HealthRevolution #ScientificStudy #LifeSavingDrugs #ResearchFindings #MedicalNews #CancerPreventionTips #Pharmaceuticals #HealthAdvice #PublicHealth #Cardiology #PreventCancer #Biology #HealthScience #InnovativeResearch #WellnessJourney #HealthcareInnovation #FutureOfMedicine #DiseasePrevention #MedicalAdvancements #StayHealthy #MedicalBreakthroughs #NewResearch #HealthyHabits #FightCancer #HealthDiscoveries #ResearchInnovation #CuttingEdgeMedicine #PreventativeHealth #HealthyChoices #ScienceBreakthroughs #StatinTherapy #PharmaNews #OncologyResearch #CholesterolManagement #HealthAndWellness #MedicalInnovation #HealthEducation #InflammationControl #ImmuneHealth #PreventDisease #ScienceFacts #HealthBreakthroughs #NewHealthFindings #MedicalScience #CancerFighting #HealthExplained #ResearchBreakthroughs #MedicalDiscoveries #HealthNews #BreakthroughScience

What if the scientific societies consider a “trendy” drug as any other, leaving out the ideology and giving #evidence-based recommendations? This is what The Multinational Association of Supportive Care in Cancer (MASCC) did with a series of guidance documents on #cannabis for cancer symptoms such as gastrointestinal disorders, #cachexia, and cancer #pain. 💡Check out for it. #SimultaneousPalliativeCare #SupportTherapy #Guidelines

🌟 Managing Adrenal Hypofunction and Psoriasis Induced by Tislelizumab 🌟 Tislelizumab is a powerful immunotherapy drug making strides in cancer treatment, but it can bring unexpected side effects like adrenal hypofunction and psoriasis. ⚠️ Key Side Effects: Adrenal Hypofunction: Can cause fatigue, weakness, and potentially life-threatening complications. Psoriasis: A chronic skin condition causing discomfort and impacting self-image. 🔍 Management Strategies: Regular Monitoring: Baseline and periodic assessments of adrenal hormone levels. Early Identification: Regular dermatological checks for psoriatic symptoms. Patient Education: Inform patients about potential side effects and encourage prompt reporting. Proactive management ensures that patients can reap the benefits of tislelizumab while effectively managing any side effects. Let’s work together to optimize cancer treatment and support overall well-being. #CancerTreatment #Immunotherapy #Tislelizumab #AdrenalHealth #Psoriasis #PatientCare #HealthAwareness Learn More: https://lnkd.in/gg4BWe4q

📢Hot off the press! Trastuzumab deruxtecan shows anti-tumor activity in solid tumors with HER2 mutations. In a study from Dec 30, 2020 to Jan 25, 2023, 102 patients with solid tumors and activating HER2 mutations received trastuzumab deruxtecan. The objective response rate was 29.4%. 51% experienced grade 3 or worse treatment-emergent adverse events, with anaemia and decreased neutrophil count being the most common. 10% had drug-related treatment-emergent serious adverse events. 11% experienced adjudicated drug-related interstitial lung disease or pneumonitis, with 2% being fatal. These findings highlight trastuzumab deruxtecan's anti-tumor activity and safety profile in heavily pretreated patients. More detail in the article: https://ow.ly/WaUo50RxerF

Our recent research indicates that healthcare professionals (#HCPs) in the UK are expressing strong disapproval of NICE's decision not to recommend #Enhertu, a cancer drug for HER2-low #breastcancer, on the reasoning that it is not "a cost-effective use of NHS resources." This decision has sparked an online movement referred to as the #EnhertuEmergency. Discover the sentiments and opinions of HCPs online by staying updated with our latest insights. #pharma #healthcare https://lnkd.in/dFsYV88g